A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer-Reference-Cited by-同舟云学术

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Published:2011-09-02 Issue:6 Volume:1 Page:508-523
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Bertotti Andrea,Migliardi Giorgia,Galimi Francesco,Sassi Francesco,Torti Davide,Isella Claudio,Corà Davide,Di Nicolantonio Federica,Buscarino Michela,Petti Consalvo,Ribero Dario,Russolillo Nadia,Muratore Andrea,Massucco Paolo,Pisacane Alberto,Molinaro Luca,Valtorta Emanuele,Sartore-Bianchi Andrea,Risio Mauro,Capussotti Lorenzo,Gambacorta Marcello,Siena Salvatore,Medico Enzo,Sapino Anna,Marsoni Silvia,Comoglio Paolo M.,Bardelli Alberto,Trusolino Livio

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 802 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer;Biomedicine & Pharmacotherapy;2024-10

2. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13

3. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

4. Early-onset cancers: Biological bases and clinical implications;Cell Reports Medicine;2024-09

5. XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients;Nature Communications;2024-08-29